5% Dextrose Injection — Class II drug recall D-0279-2015
Terminated recall by Hospira Inc., reported 2014-12-03, distributed nationwide. Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may re
| Recall number | D-0279-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2014-10-14 |
| Classified | 2014-11-25 |
| Reported by FDA | 2014-12-03 |
| Terminated | 2015-12-28 |
| Distributed | Nationwide (US) |
| Quantity | 301,560 bags |
| Reason classes | sterility, packaging |
| NDC | 00409-7922-09 |
| Lot numbers | 09/15, 11/15, 33-094-JT, 35-028-JT |
Product
5% Dextrose Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7922-09.
Reason for recall
Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0279-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.